Literature DB >> 17380564

Intraoperative diagnosis and treatment of parathyroid cancer and atypical parathyroid adenoma.

G Ippolito1, F F Palazzo, F Sebag, C De Micco, J F Henry.   

Abstract

BACKGROUND: Distinction of parathyroid cancer from atypical parathyroid adenoma (APA) at operation is difficult. The aim of this study was to determine whether parathyroid cancer and APA have different operative findings and long-term outcomes.
METHODS: A retrospective review was undertaken of patients with suspicious or malignant parathyroid tumours treated between 1974 and 2005. Parathyroid cancer was defined as a lesion with vascular or tissue invasion, and APA as a neoplasm with broad fibrous bands, trabecular growth, mitosis and nuclear atypia.
RESULTS: Twenty-seven patients with suspicious or malignant parathyroid tumours were identified. After histological review, parathyroid cancer was confirmed in 11 patients (group 1) and 16 tumours were classified as APA (group 2). The clinical presentation and operative findings of the two types of tumour were indistinguishable. At initial surgery, seven patients in group 1 underwent en bloc resection, and four had parathyroidectomy. Four of the seven patients who had en bloc resection had recurrences. No recurrences were observed in the other seven patients in group 1 at a median follow-up of 65 months. In group 2, eight patients had en bloc resection and eight had parathyroidectomy; no patient had recurrence at a median follow-up of 91 months.
CONCLUSION: Operative findings cannot distinguish APA from parathyroid cancer reliably. Without evidence of macroscopic local invasion, the value of en bloc resection at initial surgery remains debatable.

Entities:  

Mesh:

Year:  2007        PMID: 17380564     DOI: 10.1002/bjs.5570

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  26 in total

1.  Lymph node involvement and surgical approach in parathyroid cancer.

Authors:  Klaus-Martin Schulte; Nadia Talat; John Miell; Caje Moniz; Prakash Sinha; Salvador Diaz-Cano
Journal:  World J Surg       Date:  2010-11       Impact factor: 3.352

2.  Development of a formula to predict parathyroid carcinoma in patients with primary hyperparathyroidism.

Authors:  Elias Karakas; Hans-Helge Müller; Vladimir K Lyadov; Stephanie Luz; Ralph Schneider; Matthias Rothmund; Detlef K Bartsch; Katja Schlosser
Journal:  World J Surg       Date:  2012-11       Impact factor: 3.352

3.  Synchronous parathyroid carcinoma, parathyroid adenoma, and papillary thyroid carcinoma in a patient with severe and long-standing hyperparathyroidism.

Authors:  Melanie Goldfarb; Patrick O'Neal; Judy L Shih; Pamela Hartzband; James Connolly; Per-Olof Hasselgren
Journal:  Endocr Pract       Date:  2009 Jul-Aug       Impact factor: 3.443

4.  Parafibromin and APC as screening markers for malignant potential in atypical parathyroid adenomas.

Authors:  C Christofer Juhlin; Inga-Lena Nilsson; Kenth Johansson; Felix Haglund; Andrea Villablanca; Anders Höög; Catharina Larsson
Journal:  Endocr Pathol       Date:  2010-09       Impact factor: 3.943

5.  Immunohistochemical Expression of E-Cadherin in Atypical Parathyroid Adenoma.

Authors:  Ralph Schneider; Stefanie Bartsch-Herzog; Annette Ramaswamy; Detlef K Bartsch; Elias Karakas
Journal:  World J Surg       Date:  2015-10       Impact factor: 3.352

Review 6.  Understanding the genetic basis of parathyroid carcinoma.

Authors:  Anthony J Gill
Journal:  Endocr Pathol       Date:  2014-03       Impact factor: 3.943

7.  Absence of nucleolar parafibromin immunoreactivity in subsets of parathyroid malignant tumours.

Authors:  C Christofer Juhlin; Felix Haglund; Takao Obara; Andrew Arnold; Catharina Larsson; Anders Höög
Journal:  Virchows Arch       Date:  2011-01-08       Impact factor: 4.064

8.  Parathyroid carcinoma encountered after minimally invasive focused parathyroidectomy may not require further radical surgery.

Authors:  Christine J O'Neill; Conan Chan; James Symons; Diana L Learoyd; Stan B Sidhu; Leigh W Delbridge; Anthony Gill; Mark S Sywak
Journal:  World J Surg       Date:  2011-01       Impact factor: 3.352

9.  Parafibromin, galectin-3, PGP9.5, Ki67, and cyclin D1: using an immunohistochemical panel to aid in the diagnosis of parathyroid cancer.

Authors:  Peter P Truran; Sarah J Johnson; Richard D Bliss; Thomas W J Lennard; Sebastian R Aspinall
Journal:  World J Surg       Date:  2014-11       Impact factor: 3.352

Review 10.  Non-functional parathyroid carcinoma: a review of the literature and report of a case requiring extensive surgery.

Authors:  Benjamin J Wilkins; James S Lewis
Journal:  Head Neck Pathol       Date:  2009-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.